Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

Per Odin; K. Ray Chaudhuri; Jens Volkmann; Angelo Antonini; Alexander Storch; Espen Dietrichs; Zvezdan Pirtošek; Tove Henriksen; Malcolm Horne; David Devos; Filip Bergquist

doi:10.1038/s41531-018-0051-7

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

Per Odin^*, K. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

62 Citations (Scopus)

Abstract

Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.

Original language	English
Article number	14
Journal	npj Parkinson's Disease
Volume	4
Issue number	1
DOIs	https://doi.org/10.1038/s41531-018-0051-7
Publication status	Published - 1 Dec 2018

Access to Document

10.1038/s41531-018-0051-7

Cite this

Odin, P., Chaudhuri, K. R., Volkmann, J., Antonini, A., Storch, A., Dietrichs, E., Pirtošek, Z., Henriksen, T., Horne, M., Devos, D., & Bergquist, F. (2018). Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease. npj Parkinson's Disease, 4(1), Article 14. https://doi.org/10.1038/s41531-018-0051-7

@article{c74ffee4347c4514ab9ec7064e80935c,

title = "Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson{\textquoteright}s disease",

abstract = "Motor aspects of Parkinson{\textquoteright}s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson{\textquoteright}s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.",

author = "Per Odin and Chaudhuri, {K. Ray} and Jens Volkmann and Angelo Antonini and Alexander Storch and Espen Dietrichs and Zvezdan Pirto{\v s}ek and Tove Henriksen and Malcolm Horne and David Devos and Filip Bergquist",

year = "2018",

month = dec,

day = "1",

doi = "10.1038/s41531-018-0051-7",

language = "English",

volume = "4",

journal = "npj Parkinson's Disease",

issn = "2373-8057",

publisher = "Springer Nature",

number = "1",

}

Odin, P, Chaudhuri, KR, Volkmann, J, Antonini, A, Storch, A, Dietrichs, E, Pirtošek, Z, Henriksen, T, Horne, M, Devos, D & Bergquist, F 2018, 'Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease', npj Parkinson's Disease, vol. 4, no. 1, 14. https://doi.org/10.1038/s41531-018-0051-7

TY - JOUR

T1 - Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

AU - Odin, Per

AU - Chaudhuri, K. Ray

AU - Volkmann, Jens

AU - Antonini, Angelo

AU - Storch, Alexander

AU - Dietrichs, Espen

AU - Pirtošek, Zvezdan

AU - Henriksen, Tove

AU - Horne, Malcolm

AU - Devos, David

AU - Bergquist, Filip

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.

AB - Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.

UR - http://www.scopus.com/inward/record.url?scp=85052232531&partnerID=8YFLogxK

U2 - 10.1038/s41531-018-0051-7

DO - 10.1038/s41531-018-0051-7

M3 - Review article

AN - SCOPUS:85052232531

SN - 2373-8057

VL - 4

JO - npj Parkinson's Disease

JF - npj Parkinson's Disease

IS - 1

M1 - 14

ER -

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this